These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 13963935)

  • 1. [N1, N2-disubstituted hydrazines and monomine oxidase].
    HOFFMANN C; FROSSARD J; MAI-XUAN K; KARADAVIDOFF I
    Ann Pharm Fr; 1962 Jun; 20():539-44. PubMed ID: 13963935
    [No Abstract]   [Full Text] [Related]  

  • 2. [INHIBITION OF CHOLINE OXIDASE IN VIVO BY NEUROPHARMACOLOGICAL AGENTS].
    GOESCHKE H; BURKARD WP; GEY KF; PLETSCHER A
    Med Exp Int J Exp Med; 1963; 8():256-64. PubMed ID: 14044349
    [No Abstract]   [Full Text] [Related]  

  • 3. [AMINO-OXIDASES].
    ARVY L
    Ann Histochim; 1963; 8():379-82. PubMed ID: 14172009
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1961 Mar; 3():241-52. PubMed ID: 13896916
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540
    [No Abstract]   [Full Text] [Related]  

  • 6. [EFFECT OF ALPHA-SUBSTITUTED BETA-(2-METHYL-3-INDOLYL)-PROPIONIC ACID HYDRAZIDES ON THE ACTIVITY OF BRAIN MONOAMINO OXIDASES].
    SAFRAZBEKIAN RR; SUKASIAN RS
    Farmakol Toksikol; 1964; 27():213-7. PubMed ID: 14193091
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoamine oxidase inhibitors and angina pectoris.
    WINSOR T; ZARCO P
    Angiology; 1960 Feb; 11():67-75. PubMed ID: 13845298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Demonstration of the "group toxicity" of certain monoamino-oxidase inhibitors. Comparison of their mode of action with that of amphetamine].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1962; 156():1238-45. PubMed ID: 13952219
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 11. HYPOTENSIVE COLLAPSE AND HYPOGLYCAEMIA AFTER MEBANAZINE--A MONOAMINE-OXIDASE INHIBITOR.
    COOPER AJ; KEDDIE KM
    Lancet; 1964 May; 1(7343):1133-4. PubMed ID: 14132631
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors and vascular disease.
    FISHBEIN M
    Angiology; 1960 Feb; 11():53-4. PubMed ID: 13823176
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of the monoamine oxidase inhibitors in cardiovascular disease.
    GRIFFITH GC
    Am J Cardiol; 1960 Dec; 6():1103-5. PubMed ID: 13708592
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical toxicity studies of a monoamine oxidase inhibitor.
    GREENBLATT IJ; KAHN A
    Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome.
    FRIEDGOOD CE
    Angiology; 1960 Feb; 11():84-5. PubMed ID: 13825069
    [No Abstract]   [Full Text] [Related]  

  • 17. TREATMENT OF DIABETICS WITH MONOAMINE-OXIDASE INHIBITORS.
    WICKSTROM L; PETTERSSON K
    Lancet; 1964 Nov; 2(7367):995-7. PubMed ID: 14201672
    [No Abstract]   [Full Text] [Related]  

  • 18. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties.
    HORWITZ D; SJOERDSMA A
    Proc Soc Exp Biol Med; 1961 Jan; 106():118-20. PubMed ID: 13716049
    [No Abstract]   [Full Text] [Related]  

  • 19. Stupor from dextroamphetamineamobarbital and monoamine oxidase inhibitor, phenelzine.
    ROECKER RD; LANE M
    J Med Soc N J; 1961 Feb; 58():47-9. PubMed ID: 13742660
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivatives of hydrazides and hydrazines inhibiting monoamine oxidase. Mechanisms cited to account for their pharmacological effects].
    LEVY J
    Actual Pharmacol (Paris); 1961; 14():125-73. PubMed ID: 14464772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.